MASK-air: an OECD (Organisation for Economic Co-operation and Development) best practice for public health on integrated care for chronic diseases
In the recent report of the Organisation for Economic Co-operation and Development
(OECD) on Best Practices (BPs) for Integrating Care to Prevent and Manage Chronic …
(OECD) on Best Practices (BPs) for Integrating Care to Prevent and Manage Chronic …
UCRAID (Ukrainian Citizen and refugee electronic support in Respiratory diseases, Allergy, Immunology and Dermatology) action plan
Eight million Ukrainians have taken refuge in the European Union. Many have asthma
and/or allergic rhinitis and/or urticaria, and around 100,000 may have a severe disease …
and/or allergic rhinitis and/or urticaria, and around 100,000 may have a severe disease …
Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paper
Introduction In allergic asthma patients, one of the more common phenotypes might benefit
from allergen immunotherapy (AIT) as add‐on intervention to pharmacological treatment …
from allergen immunotherapy (AIT) as add‐on intervention to pharmacological treatment …
Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air® approach
MASK‐air®, a validated mHealth app (Medical Device regulation Class IIa) has enabled
large observational implementation studies in over 58,000 people with allergic rhinitis …
large observational implementation studies in over 58,000 people with allergic rhinitis …
Academic productivity of young people with allergic rhinitis: a MASK-air study
Background Several studies have suggested an impact of allergic rhinitis on academic
productivity. However, large studies with real-world data (RWD) are not available. Objective …
productivity. However, large studies with real-world data (RWD) are not available. Objective …
Digitally‐enabled, person‐centred care (PCC) in allergen immunotherapy: An ARIA‐EAACI Position Paper
O Pfaar, B Sousa‐Pinto, NG Papadopoulos… - Allergy, 2024 - Wiley Online Library
In rhinitis and asthma, several mHealth apps have been developed but only a few have
been validated. However, these apps have a high potential for improving person‐centred …
been validated. However, these apps have a high potential for improving person‐centred …
The allergic rhinitis and its impact on asthma (ARIA) approach of value-added medicines: As-needed treatment in allergic rhinitis
Drug repurposing is a major field of value-added medicine. It involves investigating and
evaluating existing drugs for new therapeutic purposes that address unmet healthcare …
evaluating existing drugs for new therapeutic purposes that address unmet healthcare …
[HTML][HTML] Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app
Background The self-reporting of asthma frequently leads to patient misidentification in
epidemiological studies. Strategies combining the triangulation of data sources may help to …
epidemiological studies. Strategies combining the triangulation of data sources may help to …
Control of allergic rhinitis and asthma test: a systematic review of measurement properties and COSMIN analysis
RJ Vieira, B Sousa‐Pinto… - Clinical and …, 2022 - Wiley Online Library
Abstract The Control of Allergic Rhinitis and Asthma Test (CARAT) is a patient‐reported
outcome measurement (PROM) assessing the control of asthma and allergic rhinitis (AR) at …
outcome measurement (PROM) assessing the control of asthma and allergic rhinitis (AR) at …
Patient‐centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA‐EAACI approach–ARIA‐EAACI Task Force Report
Biomarkers for the diagnosis, treatment and follow‐up of patients with rhinitis and/or asthma
are urgently needed. Although some biologic biomarkers exist in specialist care for asthma …
are urgently needed. Although some biologic biomarkers exist in specialist care for asthma …